RL18A Polyclonal Antibody

Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a member of the L18AE family of ribosomal proteins that is a component of the 60S subunit. The encoded protein may play a role in viral replication by interacting with the hepatitis C virus internal ribosome entry site (IRES). This gene is co-transcribed with the U68 snoRNA, located within the third intron. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed throughout the genome.

Introducing the RL18A Polyclonal Antibody, meticulously developed by BT Lab in collaboration with Dana Biosciences. This cutting-edge product is designed to revolutionize the field of molecular biology and facilitate groundbreaking research in various scientific disciplines.

The RL18A Polyclonal Antibody is a highly specific and sensitive tool that enables researchers to detect and analyze the expression of RL18A protein in a wide range of biological samples. With its exceptional affinity and selectivity, this antibody guarantees accurate and reliable results, ensuring the utmost precision in experimental outcomes.

Crafted with utmost care and precision, the RL18A Polyclonal Antibody exhibits exceptional performance across multiple applications, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into diverse experimental protocols, catering to the unique requirements of each research endeavor.

The RL18A Polyclonal Antibody is meticulously manufactured using state-of-the-art techniques and quality-controlled processes. This ensures batch-to-batch consistency, guaranteeing reproducibility and reliability in every experiment. Furthermore, the antibody is rigorously validated through extensive testing, ensuring its exceptional performance and accuracy.

BT Lab and Dana Biosciences are committed to providing researchers with the highest quality tools to advance scientific knowledge and drive innovation. The RL18A Polyclonal Antibody stands as a testament to this commitment, offering researchers an invaluable resource to unravel the complexities of RL18A protein expression and its implications in various biological processes.

In summary, the RL18A Polyclonal Antibody by BT Lab, in collaboration with Dana Biosciences, is a state-of-the-art research tool that empowers scientists to delve deeper into the intricate world of molecular biology. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to revolutionize scientific research and contribute to groundbreaking discoveries in the field.